Drug-like properties and the causes of poor solubility and poor permeability

Christopher A. Lipinski(Pfizer (United States))

Journal of Pharmacological and Toxicological Methods

July 1, 2000

10.1016/s1056-8719(00)00107-6

Cited by 3,702

Abstract

Related Papers

No related papers found

Powered by citation graph analysis